Andean Precious Metals (CVE:APM) Stock Price Down 9.6% – Here’s Why

Shares of Andean Precious Metals Corp. (CVE:APM) dropped 9.6% during trading on Tuesday . The stock traded as low as C$1.12 and last traded at C$1.13. Approximately 515,749 shares traded hands during trading, an increase of 167% from the average daily volume of 193,385 shares. The stock had previously closed at C$1.25.

Analyst Ratings Changes

Separately, Desjardins upgraded shares of Andean Precious Metals to a “moderate buy” rating in a research note on Thursday, October 31st.

Andean Precious Metals Trading Down 8.8 %

The firm has a 50-day simple moving average of C$1.46 and a two-hundred day simple moving average of C$1.25. The company has a market capitalization of C$170.27 million, a price-to-earnings ratio of 3.00 and a beta of 1.22.

Insider Activity

In other news, insider 2176423 Ontario Ltd. bought 84,400 shares of the company’s stock in a transaction that occurred on Tuesday, October 8th. The shares were purchased at an average price of C$1.51 per share, for a total transaction of C$127,359.60. In the last 90 days, insiders have acquired 306,200 shares of company stock worth $432,953. 69.37% of the stock is owned by corporate insiders.

About Andean Precious Metals

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.